Purines: From premise to promise

Journal of the Autonomic Nervous System

Volumn 81, Issue 1-3, 2000, Pages 285-288

  Williams, Michael ^a  

^a Pharmaceutical Products Division   (United States)

Author keywords

P2X and P2Y families; Purinergic research; Therapeutic area

Indexed keywords

PURINE DERIVATIVE; PURINE P2 RECEPTOR;

CHRONIC BRONCHITIS; CONTRACEPTION; CYSTIC FIBROSIS; KNOCKOUT MOUSE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; TRANSGENIC MOUSE;

EID: 0034601149     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(00)00153-3     Document Type: Article

References (27)

1. Abbracchio M.P., Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther. 64:1994;445-475.
2. 3H]-xanthine. Proc. Natl. Acad. Sci. USA. 77:1980;5547-5551.
3. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of purinoceptor? Gen. Pharmacol. 16:1985;433-440.
4. Chen C.C., Akopina A.N., Sivilotti L., Colquhoun D., Burnstock G., Wood J.N. A P2X purinoceptor expressed by a subset of sensory neurons. Nature. 377:1995;428-431.
5. 3-deficient mice display urinary bladder hyporeflexia and reduced nocifensive behavior. Drug Dev. Res. 2000;. In press.
6. Dubyak G., El-Moatassim C. Signal transduction via-P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265:1993;C577-C606.
7. Gordon J.L. Extracellular ATP: effects, sources and fate. Biochem. J. 233:1986;309-319.
8. 2T receptor: a novel approach to antithrombotic therapy. J. Med. Chem. 42:1999;213-220.
9. Jacobson K.A., van Rhee A.M. Development of selective purinoceptor agonist and antagonists. Jacobson K.A., Jarvis M.F. Purinergic Approaches in Experimental Therapeutics. 1997;101-128 Wiley-Liss, New York.
10. Khakh, B.S., Sydes, J., Labarca, C., 2000. Properties of channels formed by coexpression of nicotinic and P2X subunits, in press.
11. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature. 377:1995;432-435.
12. 1 receptors. Nature. 403:2000;86-89.
13. 3 receptors form stable trimers: a novel structural motif of ligand-gate ion channels. EMBO J. 17:1998;3016-3028.
14. North R.A. P2X purinoceptor plethora. Semin. Neurosci. 8:1996;187-194.
15. North R.A., Surprenant A. Pharmacology of cloned P2X receptors. Ann. Rev. Pharmacol. Toxicol. 40:2000;563-580.
16. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:1998;413-492.
17. Rathbone M.P., Middlemiss P.J., Gysbers J.W., Andrew C., Herman M.A.R., Redd J.K., Ciccarelli R., Di Iorio P., Caciagli R. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 56-59:1999;663-690.
18. Schulman E.S., Glaum M.C., Post T., Wang Y., Raible D.G., Mohanty J., Butterfield J.H., Pelleg A. ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am. J. Respir. Cell Mol. Biol. 20:1999;530-537.
19. Stutts M.J., Boucher R.C. Cystic fibrosis gene and functions of CFTR implications of dysfunctional ion transport for pulmonary pathogenesis. Yankaskas J.R., Knowles M.R. Cystic Fibrosis in Adults. 1999;3-25 Lippincott-Raven, Philadelphia.
20. 7). Science. 272:1996;735-738.
21. 5 receptor subunits reveals a novel ATP-gated ion channel. J. Biol. Chem. 274:1999;6653-6659.
22. Triggle D.J. Chemical diversity. Enna S.J., Williams M. Current Protocols Pharmacol. 1998;9.0.1-9.0.18 Wiley, New York.
23. 35S]-ADPβS as radioligands for ionotropic and metabotropic P2 receptor binding. Drug Dev. Res. 48:1999;84-93.
24. 2-Purinoceptors: Localization, Function and Transduction Mechanisms. CIBA Foundation Symposium 198. 1996;309-321 John Wiley, Chichester, UK.
25. Williams M. Developments in P2 receptor targeted therapeutics. Prog. Brain. Res. 120:1999;93-106.
26. 3H]-adenosine, a stable analog of adenosine. Proc. Natl. Acad. Sci. USA. 77:1980;6892-6895.
27. Williams M., Jarvis M.F. Purinergic and pyrimidinergic receptors as potential drug targets. Biochem. Pharmacol. 59:2000;1173-1185.